Skip to main content

Sub menu

News and Community
About us

Search

Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

You are here

Home
Guidance and resources
Sponsors

Medis Pharma Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (1052)
ARTG (149)
Cancellation or suspension (26)
Listed medicine compliance report (5)
Prescription medicine registration (2)

Date

2024 (866)
2023 (3)
2022 (29)
2021 (106)
2020 (31)
2019 (6)
2018 (6)
2017 (47)
2016 (5)
2015 (29)
2014 (29)
2013 (29)
2012 (23)
2011 (12)
2010 (3)
2009 (8)
2008 (1)
1993 (1)

Results for "[search-keyword]"

Search

Sponsor content

1234 result(s) found, displaying 1 to 10

PRAVASTATIN-DP pravastatin sodium 20 mg tablets blister pack Cancelled under Section 30(1)(c) of the Act

18 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
PRAVASTATIN-DP pravastatin sodium 10 mg tablets blister pack Cancelled under Section 30(1)(c) of the Act

18 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
SIMVASTATIN-SPIRIT 80 simvastatin 80 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

18 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
SIMVASTATIN-SPIRIT 40 simvastatin 40 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

18 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
SIMVASTATIN-SPIRIT 20 simvastatin 20 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

18 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
SIMVASTATIN-SPIRIT 10 simvastatin 10 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

18 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
SIMVASTATIN-SPIRIT 5 simvastatin 5 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

18 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
SIMVASTATIN-SPIRIT 5 simvastatin 5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

18 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
ZINDACLIN clindamycin (as clindamycin phosphate) 1% topical gel tube Cancelled under Section 30(1)(c) of the Act

18 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
AMLODIPINE SPIRIT 10 amlodipine (as maleate) 10mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

18 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd

Pages

Current page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.

© Commonwealth of Australia